Profit and Loss Results Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 19.80% vs -5.57% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is -34.88% vs -42.35% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is 6.61% vs 52.60% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is -14.09% vs 24.20% in Mar 2024
Compare Profit and Loss Results of Aarey Drugs
Figures in Cr
standalone - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
473.00
1,908.00
-1,435.00
-75.21%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
238.00
-238.00
-100.00%
Net Sales
473.00
1,669.00
-1,196.00
-71.66%
Expenditure (Ex Depriciation)
Stock Adjustments
-10.00
117.00
-127.00
-108.55%
Raw Materials Consumed
472.00
1,250.00
-778.00
-62.24%
Power & Fuel Cost
0.00
103.00
-103.00
-100.00%
Employee Cost
0.00
96.00
-96.00
-100.00%
Operating Expenses
1.00
59.00
-58.00
-98.31%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
3.00
46.00
-43.00
-93.48%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
0.00
3.00
-3.00
-100.00%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
471.00
1,699.00
-1,228.00
-72.28%
Operating Profit (PBDIT) excl Other Income
2.00
-29.00
31.00
106.90%
Other Income
9.00
4.00
5.00
125.00%
Operating Profit (PBDIT)
12.00
-24.00
36.00
150.00%
Interest
4.00
74.00
-70.00
-94.59%
Profit before Depriciation and Tax
8.00
-99.00
107.00
108.08%
Depreciation
1.00
62.00
-61.00
-98.39%
Profit Before Taxation & Exceptional Items
6.00
-161.00
167.00
103.73%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
6.00
-161.00
167.00
103.73%
Provision for Tax
2.00
-47.00
49.00
104.26%
Profit After Tax
4.00
-113.00
117.00
103.54%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
53.00
703.00
-650.00
-92.46%
Profit Available for appropriations
57.00
590.00
-533.00
-90.34%
Appropriations
57.00
590.00
-533.00
-90.34%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
1.42
-5.07
6.49
128.01%
Profit And Loss - Net Sales
Net Sales 473.94 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 19.80% vs -5.57% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 2.90 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -34.88% vs -42.35% in Mar 2024
Profit And Loss - Interest
Interest 4.66 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 6.61% vs 52.60% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 4.02 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -14.09% vs 24.20% in Mar 2024
